1. Home
  2. JF vs QNRX Comparison

JF vs QNRX Comparison

Compare JF & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J and Friends Holdings Limited American Depositary Shares

JF

J and Friends Holdings Limited American Depositary Shares

N/A

Current Price

$1.08

Market Cap

16.2M

Sector

N/A

ML Signal

N/A

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$5.41

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JF
QNRX
Founded
2012
2018
Country
China
United States
Employees
78
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
14.5M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
JF
QNRX
Price
$1.08
$5.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.3K
32.7K
Earning Date
04-24-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.89
$5.32
52 Week High
$1.12
$41.80

Technical Indicators

Market Signals
Indicator
JF
QNRX
Relative Strength Index (RSI) 64.61 33.95
Support Level $0.90 N/A
Resistance Level N/A $6.98
Average True Range (ATR) 0.07 0.50
MACD 0.01 -0.01
Stochastic Oscillator 91.97 10.95

Price Performance

Historical Comparison
JF
QNRX

About JF J and Friends Holdings Limited American Depositary Shares

J and Friends Holdings Ltd, formerly Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: